Decreased rate of germination and ability to establish colony growth by <i>A. fumigatus</i> isolate Af5517. by Nansalmaa Amarsaikhan (580405)

“…<p>(<b>A,B</b>) Flow cytometric analysis of conidial swelling in <i>A. fumigatus</i> isolates during 5 hours of incubation at 37°C. (<b>A</b>) Representative histograms from three experiments of forward scatter (FSC) from each isolate at 0 and 5 hours. …”

Decreased rate of germination and ability to establish colony growth by <i>A. fumigatus</i> isolate Af5517. by Nansalmaa Amarsaikhan (580405)

“…<p>(<b>A,B</b>) Flow cytometric analysis of conidial swelling in <i>A. fumigatus</i> isolates during 5 hours of incubation at 37°C. (<b>A</b>) Representative histograms from three experiments of forward scatter (FSC) from each isolate at 0 and 5 hours. …”

Direction and magnitude of change in TOL group vs. non-TOL and control: Genes with decreased expression in TOL group. by Joseph Pidala (702976)

DLS mGluR1/5 signaling activation in instrumental conditioning and differential behavioral sensitivity to A–O changes with training duration. by Vincent Paget-Blanc (21807763)

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

Decreased LysoTracker-positive vacuoles containing <i>S. aureus</i> in <i>PRIP</i>-DKO MEFs. by Kae Harada-Hada (568788)

Deciphering Nonbioavailable Substructures Improves the Bioavailability of Antidepressants by Serotonin Transporter by Zhi-Zheng Wang (6056033)

Deciphering Nonbioavailable Substructures Improves the Bioavailability of Antidepressants by Serotonin Transporter by Zhi-Zheng Wang (6056033)

Deciphering Nonbioavailable Substructures Improves the Bioavailability of Antidepressants by Serotonin Transporter by Zhi-Zheng Wang (6056033)

Deciphering Nonbioavailable Substructures Improves the Bioavailability of Antidepressants by Serotonin Transporter by Zhi-Zheng Wang (6056033)

Deciphering Nonbioavailable Substructures Improves the Bioavailability of Antidepressants by Serotonin Transporter by Zhi-Zheng Wang (6056033)

(A) Decreased DNA CpG methylation at the CpG island of the gene locus in Th2 cells by Masakatsu Yamashita (46657)

“…MeDIP assay was performed using an anti–5-methyl cytidine antibody (5-meC) and a control antibody (Cont.). …”

Spacer decreases p53 transactivation, promoter occupancy and binding in yeast and mammalian cells and <i>in vitro</i>. by Jennifer J. Jordan (53318)

Block-based RMSD analysis of the native protein-DNA complex. by Sneha P. (3926957)

AT2R blocker reduces T3-induced decreased levels of contractile proteins and attenuates T3-induced NO production. by Maria Alícia Carrillo-Sepúlveda (406779)

“…Data are expressed as mean ± SD (n = 5 per group for A and B; n = 4 per group for C and D; *p<0.05 <i>vs.…”

FBP primarily decreases the protein level of HMGB1 by promoting its lysosomal degradation upon viral infection. by Penghui Hu (695020)